Salicylic acid

Description

No relevant information is available for the Description section associated with SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The recommended dosage for the treatment of acne is to apply the stick directly to the affected area. The application should be performed once or twice daily, depending on the severity of the condition and the patient's response to treatment.

Prior to application, the affected area should be cleansed and dried thoroughly. The stick should be applied gently to the skin, ensuring even coverage over the affected areas. Care should be taken to avoid contact with the eyes and mucous membranes.

Patients are advised to monitor their skin's response to the treatment and adjust the frequency of application as necessary, based on tolerance and clinical improvement. If irritation or excessive dryness occurs, it may be beneficial to reduce the frequency of application or discontinue use temporarily.

Healthcare professionals should instruct patients to follow these guidelines closely to optimize treatment outcomes while minimizing potential side effects.

Contraindications

Use of this product is contraindicated in patients with very sensitive skin or those with a known sensitivity to benzoyl peroxide. Due to the potential for adverse reactions, individuals with these conditions should avoid use.

Warnings and Precautions

For external use only. This product is not intended for internal use and should be applied solely as directed.

General precautions must be observed to ensure safe usage. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate assistance should be sought by contacting a Poison Control Center or seeking emergency medical help. Users should avoid contact with the eyes; should contact occur, the affected area must be flushed thoroughly with water.

Individuals with very sensitive skin or those who have a known sensitivity to benzoyl peroxide should refrain from using this product to prevent adverse reactions.

In cases where irritation becomes severe, it is advised to discontinue use immediately. If irritation persists despite discontinuation, consultation with a healthcare professional is recommended.

Side Effects

For external use only. No specific adverse reactions have been reported in clinical trials or postmarketing experiences. Patients should be advised to adhere strictly to the recommended usage guidelines to minimize the risk of adverse effects.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one topical acne medication unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Cover Patch. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate assistance should be sought by contacting a Poison Control Center. Additionally, care should be taken to avoid contact with the eyes; if contact occurs, the affected area should be flushed thoroughly with water.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that there is no specific information regarding the use of this product during pregnancy provided in the prescribing information. Additionally, there are no statements indicating whether the product is contraindicated in pregnancy or any associated risks to the fetus. As such, healthcare professionals should exercise caution and consider the lack of data when prescribing this product to pregnant patients. No dosage modifications or special precautions regarding use during pregnancy are mentioned, highlighting the need for careful clinical judgment in these cases.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of activated charcoal may be considered to limit further absorption of the substance, provided that the patient is alert and able to protect their airway.

In cases where specific antidotes are known, they should be administered as per established protocols. Continuous assessment and supportive measures are critical in managing the patient's condition until they stabilize.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult local poison control centers for additional guidance tailored to the specific situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek help or contact a Poison Control Center immediately. It is important to emphasize avoiding contact with the eyes; if contact occurs, patients should flush the area thoroughly with water.

Patients should be informed not to use this product if they have very sensitive skin or if they are known to be sensitive to benzoyl peroxide. Additionally, they should be cautioned to keep the product away from the eyes, lips, and mouth.

Healthcare providers should recommend that patients avoid unnecessary sun exposure while using this product and encourage the use of sunscreen to protect their skin. Patients should also be made aware that contact with hair or dyed fabrics, including carpets and clothing, should be avoided, as this product may cause bleaching.

Patients may experience skin irritation, which can manifest as redness, burning, itching, peeling, or possibly swelling. It is advisable to inform patients that mild irritation may be alleviated by using the product less frequently or in a lower concentration. If irritation becomes severe, patients should discontinue use and consult a doctor if irritation persists.

Furthermore, healthcare providers should caution patients against using other topical acne medications simultaneously or immediately after applying this product, as this may increase dryness or irritation of the skin. If such reactions occur, patients should be advised to use only one medication unless directed otherwise by a healthcare professional.

Storage and Handling

The product is supplied in a tightly closed container to maintain its integrity. It is essential to avoid exposure to extreme temperatures, specifically below 40°F and above 100°F, to ensure optimal stability and efficacy. Proper storage conditions are crucial for preserving the quality of the product.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area 1 to 3 times daily. Should patients experience bothersome dryness or peeling, it is advised to reduce the frequency of application to once daily. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Acne Cover Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)